Σελίδα 1 από 27 Αποτελέσματα
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the field of cancer treatment. More particularly, it concerns methods of generating DHA-containing lipid nanoparticles and their use in the treatment of cancer.
2. Description of Related Art
In recent
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable
REFERENCE TO A "MICROFICHE APPENDIX"
Not applicable
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to hydroquinone substituted polyunsaturated fatty acids. More particularly, the
TECHNICAL FIELD
The invention relates to therapeutic agents and methods for treating cancer, and especially for overcoming multidrug resistance, including multidrug resistance in cancer stem cells. In particular, the invention relates to nanoemulsion formulations and delivery systems for taxoid
FIELD OF THE DISCLOSURE
The present document relates to the field of medicinal chemistry. More particularly it relates to the field of active agents used as cancer chemopreventive agent and radioenhencer for radiotherapy of cancer.
BACKGROUND OF THE DISCLOSURE
An estimated 153,100 new cases of
FIELD OF THE DISCLOSURE
The present document relates to the field of medicinal chemistry. More particularly it relates to the field of active agents used as cancer chemopreventive agent and radioenhencer for radiotherapy of cancer.
BACKGROUND OF THE DISCLOSURE
An estimated 153,100 new cases of
FIELD OF THE DISCLOSURE
The present document relates to the field of medicinal chemistry. More particularly it relates to the field of active agents used as cancer chemopreventive agent and radioenhencer for radiotherapy of cancer.
BACKGROUND OF THE DISCLOSURE
An estimated 153,100 new cases of
FIELD OF THE DISCLOSURE
The present document relates to the field of medicinal chemistry. More particularly it relates to the field of active agents used as cancer chemopreventive agent and radioenhencer for radiotherapy of cancer.
BACKGROUND OF THE DISCLOSURE
An estimated 153,100 new cases of
FIELD OF THE DISCLOSURE
The present disclosure relates to the field of medicinal chemistry. More particularly, it relates to polyunsaturated fatty acid monoglyceride compounds and derivatives thereof. It also relates to compositions which comprise such compounds. There is also provided a method for
FIELD OF THE DISCLOSURE
The present disclosure relates to the field of medicinal chemistry. More particularly, it relates to polyunsaturated fatty acid monoglyceride compounds and derivatives thereof. It also relates to compositions which comprise such compounds. There is also provided a method for
FIELD OF THE DISCLOSURE
The present disclosure relates to the field of medicinal chemistry. More particularly, it relates to polyunsaturated fatty acid monoglyceride compounds and derivatives thereof. It also relates to compositions which comprise such compounds. There is also provided a method for
FIELD OF THE DISCLOSURE
The present disclosure relates to the field of medicinal chemistry. More particularly, it relates to polyunsaturated fatty acid monoglyceride compounds and derivatives thereof. It also relates to compositions which comprise such compounds. There is also provided a method for
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to methods for selectively occluding blood vessels which supply neoplastic tissue, including tumors.
2. Description of the Related Art
The polyunsaturated fatty acids (PUFAs) are fatty acids having at least two
TECHNICAL FIELD
This invention relates to a method for enhancing existing cancer therapies by additionally administering unsaturated fatty acids to a patient. More particularly, this invention relates to a method for enhancing existing breast cancer therapies such as surgery, chemo-, hormone- and
BACKGROUND
Pancreatic cancer is the fourth most common cause of cancer-related deaths in the United States and the eight worldwide. The Pancreatic Cancer Action Network.TM. predicted that it will move from the 4.sup.th to the 2.sup.nd leading cause of cancer death in the US by 2020 or earlier, based
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a method of reducing damage to skin and mucosa in pet animals such as dogs and cats wherein the pet is afflicted with cancer and is subjected to radiation therapy, the method including a food composition to be